Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione
Tushar Kanti Das, Alborz Javadzadeh, Avyarthana Dey, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 91, pp. 94-102
Closed Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Anti- and pro-oxidant properties of polyphenols and their role in modulating glutathione synthesis, activity and cellular redox potential: Potential synergies for disease management
Courage Sedem Dzah, Haihui Zhang, Vera Afua Dela Gobe, et al.
Advances in Redox Research (2024) Vol. 11, pp. 100099-100099
Open Access | Times Cited: 20
Potential Roles of Redox Dysregulation in the Development of Schizophrenia
Diana O. Perkins, Clark Jeffries, Kim Q.
Biological Psychiatry (2020) Vol. 88, Iss. 4, pp. 326-336
Open Access | Times Cited: 85
Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings
Giselli Scaini, Samira S. Valvassori, Alexandre Paim Díaz, et al.
Brazilian Journal of Psychiatry (2020) Vol. 42, Iss. 5, pp. 536-551
Open Access | Times Cited: 82
Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate
Kara Dempster, Peter Jeon, Michael Mackinley, et al.
Molecular Psychiatry (2020) Vol. 25, Iss. 8, pp. 1640-1650
Open Access | Times Cited: 81
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
Sakiko Tsugawa, Yoshihiro Noda, Ryosuke Tarumi, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 10, pp. 1199-1214
Closed Access | Times Cited: 80
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
Michel Cuénod, Pascal Steullet, Jan-Harry Cabungcal, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 4, pp. 1886-1897
Open Access | Times Cited: 79
Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotection
Ekta Singh, D. Giles
Molecular Biology Reports (2020) Vol. 47, Iss. 4, pp. 3133-3140
Closed Access | Times Cited: 70
Insights into myelin dysfunction in schizophrenia and bipolar disorder
Marcela Valdés‐Tovar, Alejandra Monserrat Rodríguez‐Ramírez, Leslye Rodríguez-Cárdenas, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 2, pp. 264-285
Open Access | Times Cited: 60
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia
Inès Khadimallah, Raoul Jenni, Jan-Harry Cabungcal, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1192-1204
Open Access | Times Cited: 59
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 33
Crosstalk between Oxidative Stress and Aging in Neurodegeneration Disorders
Rehab F. Abdelhamid, Seiichi Nagano
Cells (2023) Vol. 12, Iss. 5, pp. 753-753
Open Access | Times Cited: 26
Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study
Min Wang, Peter B. Barker, Nicola G. Cascella, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 2018-2029
Open Access | Times Cited: 24
Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia
Jing Huang, AnMei Chen, Hua Jin, et al.
The Journal of Clinical Psychiatry (2025) Vol. 86, Iss. 1
Closed Access | Times Cited: 1
Curcumin intervention for cognitive function in different types of people: A systematic review and meta‐analysis
Longni Zhu, Xi Mei, Zeng‐Guo Zhang, et al.
Phytotherapy Research (2018) Vol. 33, Iss. 3, pp. 524-533
Closed Access | Times Cited: 61
Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4578-4597
Closed Access | Times Cited: 58
Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies
Brandon S. Pruett, James H. Meador‐Woodruff
Schizophrenia Research (2020) Vol. 223, pp. 29-42
Closed Access | Times Cited: 58
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
Valerie J. Sydnor, David R. Roalf
Schizophrenia Research (2020) Vol. 226, pp. 61-69
Open Access | Times Cited: 56
Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Giselli Scaini, Taylor Andrews, Camila Nayane de Carvalho Lima, et al.
Mitochondrion (2020) Vol. 57, pp. 23-36
Open Access | Times Cited: 52
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
Daniella Dwir, Inès Khadimallah, Lijing Xin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 309-321
Open Access | Times Cited: 17
Biomarkers of bipolar disorder based on metabolomics: A systematic review
Jin Chen, Nousayhah Amdanee, Xiaowei Zuo, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 492-503
Closed Access | Times Cited: 6
A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia
Jennifer M. Coughlin, Kun Yang, Anouk Marsman, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3502-3511
Open Access | Times Cited: 41
MicroRNAs in the Onset of Schizophrenia
Kristen T. Thomas, Stanislav S. Zakharenko
Cells (2021) Vol. 10, Iss. 10, pp. 2679-2679
Open Access | Times Cited: 38
In Vivo Brain GSH: MRS Methods and Clinical Applications
Francesca Bottino, Martina Lucignani, Antonio Napolitano, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1407-1407
Open Access | Times Cited: 36
Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
Lena Palaniyappan, Min Tae M Park, Peter Jeon, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1703-1703
Open Access | Times Cited: 36
Counteracting Effects of Glutathione on the Glutamate-Driven Excitation/Inhibition Imbalance in First-Episode Schizophrenia: A 7T MRS and Dynamic Causal Modeling Study
Roberto Limongi, Peter Jeon, Jean Théberge, et al.
Antioxidants (2021) Vol. 10, Iss. 1, pp. 75-75
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top